4Filing Date: Feb 19, 2026
West Pharmaceutical Services (WST)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000105770-26-000016
Total Value$45.5K
Trades6
Insiders1
Transaction Details
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Acquire
Common Stock
Shares+135.49
Price-
Total Value$0
Shares Owned After17.41K
Transaction DateFeb 18, 2026
Footnotes ▸
Restricted stock units convert into common stock on a one-for-one basis.
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Exercise · Dispose
Rst. Stock UnitDerivative
Shares-135.49
Price$0.00
Total Value$0
Shares Owned After408.49
Transaction DateFeb 18, 2026
Footnotes ▸
Restricted stock units convert into common stock on a one-for-one basis. | On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). | On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-35.76
Price$248.26
Total Value$8.9K
Shares Owned After17.37K
Transaction DateFeb 18, 2026
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-150.44
Price$243.19
Total Value$36.6K
Shares Owned After17.27K
Transaction DateFeb 17, 2026
Favorite Annette F
Sr. VP & Chief HR Officer·Direct
Grant · Acquire
Common Stock
Shares+441.96
Price$0.00
Total Value$0
Shares Owned After17.43K
Transaction DateFeb 17, 2026
Footnotes ▸
These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown.
Favorite Annette F
Sr. VP & Chief HR Officer·Indirect · Non-Qualified Deferred Compensation Plan
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After4.96K
Post-Transaction Holdings
Favorite Annette F · Sr. VP & Chief HR Officer
| Security | Shares | Change |
|---|---|---|
| Common Stock | 22.37K | +391.25 (1.78%) |
| Rst. Stock Unit | 408.49 | -135.49 (-24.91%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-02-17
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
--- Reporting Owner ---
Name: Favorite Annette F
CIK: 0001654975
Role: Officer (Sr. VP & Chief HR Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-02-17 | Code: A (Grant or award)
Shares: +441.957 | Price: $0.00
Shares Owned After: 17,425.1994 | Ownership: D (Direct)
Footnotes:
[F1] These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown.
[Transaction #2]
Security: Common Stock
Date: 2026-02-17 | Code: F (Payment of exercise/tax)
Shares: -150.443 | Price: $243.19
Total Value: $36,586.23
Shares Owned After: 17,274.7564 | Ownership: D (Direct)
[Transaction #3]
Security: Common Stock
Date: 2026-02-18 | Code: M (Exercise of derivative)
Shares: +135.491
Shares Owned After: 17,410.2474 | Ownership: D (Direct)
Footnotes:
[F2] Restricted stock units convert into common stock on a one-for-one basis.
[Transaction #4]
Security: Common Stock
Date: 2026-02-18 | Code: F (Payment of exercise/tax)
Shares: -35.757 | Price: $248.26
Total Value: $8,877.03
Shares Owned After: 17,374.4904 | Ownership: D (Direct)
--- Derivative Transactions ---
[Transaction #1]
Security: Rst. Stock Unit
Date: 2026-02-18 | Code: M (Exercise of derivative)
Shares: -135.491 | Price: $0.00
Shares Owned After: 408.486 | Ownership: D (Direct)
Footnotes:
[F2] Restricted stock units convert into common stock on a one-for-one basis.
[F3] On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).
[F3] On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
--- Footnotes (Complete Index) ---
F1: These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents).
--- Signature ---
/s/ /s/ Louis Lalli, as an agent for Annette Favorite (2026-02-19)